• AstraZeneca average price to free cash flow ratio for 2024 was 25.45, a 12.31% decline from 2023.
• AstraZeneca average price to free cash flow ratio for 2023 was 22.66, a 12.58% increase from 2022.
• AstraZeneca average price to free cash flow ratio for 2022 was 25.92, a 6.59% decline from 2021.

Price to free cash flow ratio can be defined as